Reuters
reuters.com
did:plc:jbvnehrrdqoulco4rf5gxg5r
Novartis faces drug pipeline test with valuation premium in focus reut.rs/4gH8tWV https://reut.rs/4gH8tWV
2026-07-20T05:10:14.068Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.